Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click on 'Find out more' to see our Cookie statement.

Oxford University has today announced the design team and funding arrangements for a major new building.

A view of Oxford colleges and spires

The replacement to the Tinbergen building in the University’s science area, provisionally called the Centre for Life and Mind Sciences, will be the largest building project the University has ever undertaken and will significantly improve the way psychological and biological science is undertaken in Oxford.

The University has appointed as architects NBBJ, supported by partners, to design the new building on the junction of St Cross Road and South Parks Road.

It has also approved £192 million in capital funding for the project, with additional funding through donor philanthropy.

The Centre will transform the educational experience for students, providing laboratories for undergraduates, postgraduates and researchers, as well as lecture theatres, specialised support laboratories and opportunities for public engagement.

The new building will also aim to facilitate the University’s public and schools outreach through shared opportunities for art, exhibitions, lectures and conferences, offering a ‘window into science’. 

Whilst it will occupy the same site as the existing Tinbergen building, it will enhance this gateway to Oxford’s Science Area and create an exciting public space with better connections to the surrounding area.

Professor Chris Kennard, the University’s senior responsible owner for the project, said: “The Centre will transform the way psychological and biological science is undertaken in Oxford, helping scientists to solve some of our major global challenges. The new Centre will transform the education experience for students, and offer new opportunities for public engagement with our research.

The Tinbergen building was the University’s largest teaching and research building before its closure in February 2017.

Work began on the site in October 2018 to safely remove all asbestos using highly specialist contractors prior to demolition, alongside the development of plans for the new building.

 Further information is available at

Similar stories

Oxford zoologists find rare wild ancestors of feral pigeons living on British and Irish islands

DNA testing reveals that rock doves, the wild ancestors of the common domestic and feral pigeons, now extinct in many parts of the world, are still living on islands in Scotland and Ireland.

Oxford Flight Group reveals how hawks control flight and landing to prioritise safety

Oxford biomechanics researchers have been using computer simulations and Hollywood-style motion capture to reveal how Harris hawks optimise their landing manoeuvres for an accurate descent.

Professor Samuel Sheppard, to join Ineos Oxford Institute to further interdisciplinary research on antimicrobial resistance

Professor Sheppard will join the Department of Biology and the IOI in September 2022, with the aim of using fundamental evolutionary and ecological theory to address consequential questions in pathogen emergence and spread.

Wytham Woods badgers studied to complete first complete genome of the European badger

The study carried out by researchers from Oxford's Department of Zoology and the Wellcome Sanger Institute, as part of the Darwen Tree of Life project, will shed new light on badger biology, disease and responses to climate change.

Nobel prize-winning Oxford biologist Niko Tinbergen honoured with Blue Plaque

The late Professor of Animal Behaviour, Niko Tinbergen, has been honoured with the plaque for his founding contributions to the field of ethology - the study of animal behaviour - which is now a recognised area of biological study.

Common drug-resistant superbug develops fast resistance to 'last resort' antibiotic

A study published today in Cell Reports reveals how populations of a bacterium called Pseudomonas respond to being treated with Colistin, a 'last resort' antibiotic for patients who have developed multi-drug resistant infections.